Answers are grounded in this paper and cite their sources.
Intracerebral hemorrhage (ICH) is a severe disease with a high mortality and morbidity. Excessive reactive oxygen species (ROS) and neuroinflammatory responses play pivotal roles in brain injuries. Conventional pharmacotherapy can only partially attenuate neuroinflammation via scavenging ROS, thereby limiting its clinical translation. To address this challenge, we developed Pt-atom-based nanoclusters (Ptc-PA) with multi-enzyme-like activity for the treatment of ICH. In vitro, Ptc-PA scavenged ROS induced by hydrogen peroxide treatment and protected neuronal cells from oxidative damage. Furthermore, Ptc-PA promoted microglial polarization from the pro-inflammatory M1 to anti-inflammatory M2 phenotype, accompanied by reduced inflammatory cytokine expression. In vivo, RNA-seq analysis suggested that MAPK and Wnt signaling pathways may be involved in the therapeutic effects of Ptc-PA, which was accompanied by the recovery of cognitive and motor functions after ICH. This Pt-cluster nanozyme offers a therapeutic strategy for ICH and potentially other central nervous system disorders.
No takes yet. Share an insight, caveat, or question.
Fang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: